NEW YORK, May 4 (GenomeWeb News) - The UK's Department of Trade and Industry has awarded CellCentric £1.15 million ($2.1 million) to support development of cell-based screens for proteins and small molecules responsible for epigenetic changes, the company said today.
The DTI's Technology Program provided the funding as part of a £2.3 million, three-year program that also includes the Gurdon Institute and the Babraham Institute at the
The epigenetic screens are expected to have applicability in bioprocessing, regenerative medicine, and cancer therapeutics, CellCentric said.